Valeant to Reduce Workforce by 15% After Bausch + Lomb Buyout

Valeant expects to reduce its combined workforce by 10 to 15 percent upon completion of the $8.7 billion Bausch + Lomb buyout, according to a Healio report.

Advertisement

The company, which employed 7,500 people before the consolidation, does not anticipate laying off workers in North America. Bausch + Lomb employs 11,000 people worldwide.

Once the reorganization is complete, Valeant will keep Bausch + Lomb’s name, and the health business will be headquartered in New Jersey. Transaction details will be finalized in early August.

More Articles on Ophthalmology:
Jules Stein Eye Institute, Doheny Eye Institute Intend to Develop Long-Term Affiliation
Southgate Surgery Center in Michigan Acquires ORA System for Cataract Surgery
Vista Eye Specialists of Virginia Uses New Toric Lens Technology to Treat Astigmatism

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.